Ashish S. Shah

ORCID: 0000-0002-1821-9110
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Mechanical Circulatory Support Devices
  • Organ Transplantation Techniques and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Renal Transplantation Outcomes and Treatments
  • Cardiac Arrest and Resuscitation
  • Cardiac Valve Diseases and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Congenital Heart Disease Studies
  • Cardiac pacing and defibrillation studies
  • Infective Endocarditis Diagnosis and Management
  • Pulmonary Hypertension Research and Treatments
  • Foot and Ankle Surgery
  • Cardiovascular Function and Risk Factors
  • Organ Donation and Transplantation
  • Heart Failure Treatment and Management
  • Cardiac and Coronary Surgery Techniques
  • Respiratory Support and Mechanisms
  • Tracheal and airway disorders
  • Hepatitis C virus research
  • Aortic Disease and Treatment Approaches
  • Intensive Care Unit Cognitive Disorders
  • Polyomavirus and related diseases
  • Orthopedic Surgery and Rehabilitation

Vanderbilt University
2016-2025

University of Alabama at Birmingham
2022-2025

Vanderbilt University Medical Center
2016-2025

Vanderbilt Health
2016-2024

University of Manitoba
2022-2024

Suamandeep Vidyapeeth University
2024

St. Boniface Hospital
2023-2024

Willis-Knighton Cancer Center
2024

Medical College of Wisconsin
2023

Charlottesville Medical Research
2023

Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors.We sought to identify donor, recipient, perioperative factors PGD.We performed a 10-center prospective cohort study enrolled between March 2002 December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society Heart Transplantation grade 3 at 48 or 72 hours post-transplant....

10.1164/rccm.201210-1865oc article EN American Journal of Respiratory and Critical Care Medicine 2013-01-11

Although accumulating data support the efficacy of intramyocardial cell-based therapy to improve left ventricular (LV) function in patients with chronic ischemic cardiomyopathy undergoing CABG, underlying mechanism and impact cell injection site remain controversial. Mesenchymal stem cells (MSCs) LV structure through several effects including reducing fibrosis, neoangiogenesis, neomyogenesis.To test hypothesis that on cardiac after injections autologous MSCs results from a concordance...

10.1161/circresaha.114.303180 article EN Circulation Research 2014-02-25

Data showing the efficacy and safety of transplantation hearts obtained from donors after circulatory death as compared with brain are limited. Download a PDF Research Summary. We conducted randomized, noninferiority trial in which adult candidates for heart were assigned 3:1 ratio to receive donor or if that was available first (circulatory-death group) only had been preserved use traditional cold storage (brain-death group). The primary end point risk-adjusted survival at 6 months...

10.1056/nejmoa2212438 article EN New England Journal of Medicine 2023-06-07
Vinayak Bapat Syed Zaid Shinichi Fukuhara Shekhar Saha Keti Vitanova and 95 more Philipp Kiefer John J. Squiers Pierre Voisine Luigi Pirelli Moritz Wyler von Ballmoos Michael Chu Josep Rodés‐Cabau J. Michael DiMaio Michael A. Borger Rüdiger Lange Christian Hagl Paolo Denti Thomas Modine Tsuyoshi Kaneko Gilbert H.L. Tang Aditya Sengupta David Holzhey Thilo Noack Katherine Harrington Siamak Mohammadi Derek R. Brinster Marvin D. Atkins Muhanad Algadheeb Rodrigo Bagur Nimesh D. Desai Oliver D. Bhadra Lenard Conradi Christian Shults Lowell F. Satler Basel Ramlawi N. Bryce Robinson Lin Wang George Petrossian Martin Andreas Paul Werner Andrea Garatti Flavien Vincent Eric Van Belle Françis Juthier Lionel Leroux John R. Doty Joshua Goldberg Hasan Ahmad Kashish Goel Ashish S. Shah Arnar Geirsson John K. Forrest Kendra J. Grubb Sameer Hirji Pinak Shah Giuseppe Bruschi Guido Gelpi Igor Belluschi Maral Ouzounian Marc Ruel Talal Al‐Atassi Jörg Kempfert Axel Unbehaun Nicholas M. Van Mieghem Thijmen W. Hokken Walid Ben Ali Réda Ibrahim Philippe Demers Alejandro Pizano Marco Di Eusanio Filippo Capestro Rodrigo Estévez‐Loureiro Miguel Piñón Michael H. Salinger Joshua D. Rovin Augusto D’Onofrio Chiara Tessari Antonio Di Virgilio Maurizio Taramasso Marco Gennari Andrea Colli Brian Whisenant Tamim Nazif Neal S. Kleiman Molly Szerlip Ron Waksman Isaac George Tom C. Nguyen Francesco Maisano G. Michael Deeb Joseph E. Bavaria Michael J. Reardon Michael J. Mack Vinayak Bapat William T. Brinkman J. Michael DiMaio Timothy J. George Katherine Harrington Michael J. Mack Srinivasa Potluri

10.1016/j.jcin.2021.07.015 article EN publisher-specific-oa КАРДИОЛОГИЯ УЗБЕКИСТАНА 2021-09-01

BackgroundHeart transplantation is an effective treatment offering the best recovery in both quality and quantity of life those affected by refractory, severe heart failure. However, limited donor organ availability. The reintroduction donation after circulatory determination death (DCD) 2014 offered uplift transplant activity 30%. Thoraco-abdominal normothermic regional perfusion (taNRP) enables in-situ reperfusion DCD heart. objective this paper to assess clinical outcomes hearts recovered...

10.1016/j.eclinm.2023.101887 article EN cc-by EClinicalMedicine 2023-03-02

Exogenous gene delivery to alter the function of heart is a potential novel therapeutic strategy for treatment cardiovascular diseases such as failure (HF). Before therapy approaches cardiac can be realized, efficient and reproducible in vivo techniques must established efficiently transfer transgenes globally myocardium. We have been testing hypothesis that genetic manipulation myocardial β-adrenergic receptor (β-AR) system, which impaired HF, enhance function. delivered adenoviral...

10.1172/jci6026 article EN Journal of Clinical Investigation 1999-07-01

When the heart fails, there is often a constellation of biochemical alterations β-adrenergic receptor (βAR) signaling system, leading to loss cardiac inotropic reserve. βAR down-regulation and functional uncoupling are mediated through enhanced activity kinase (βARK1), expression which increased in ischemic failing myocardium. These changes widely viewed as representing an adaptive mechanism, protects against chronic activation. In this study, we demonstrate, using vivo intracoronary...

10.1073/pnas.090091197 article EN Proceedings of the National Academy of Sciences 2000-04-25

Background —Genetic manipulation to reverse molecular abnormalities associated with dysfunctional myocardium may provide novel treatment. This study aimed determine the feasibility and functional consequences of in vivo β-adrenergic receptor kinase (βARK1) inhibition a model chronic left ventricular (LV) dysfunction after myocardial infarction (MI). Methods Results —Rabbits underwent ligation circumflex (LCx) marginal artery implantation sonomicrometric crystals. Baseline cardiac physiology...

10.1161/01.cir.103.9.1311 article EN Circulation 2001-03-06

Pulmonary hypertension (PH) secondary to left heart failure portends a poor prognosis and is relative contraindication transplantation at many centers. We tested the hypothesis that when PH persists after adequate ventricle unloading via recent ventricular assist device (LVAD) therapy, phosphodiesterase type 5A inhibition would decrease in this population.We performed an open-label clinical trial using control patients not receiving therapy. Between 1999 2007, 138 consecutive undergoing...

10.1161/circheartfailure.108.796789 article EN Circulation Heart Failure 2008-11-01

Introduction— Single-institution series have suggested that men receiving orthotopic heart transplantation from female donors decreased survival. No multi-institutional has comprehensively addressed the issue of donor and recipient sex matching for both male recipients. Methods Results— We used data prospectively collected United Network Organ Sharing open cohort to review 18 240 adult patients who received 1999 2007. Four strata were identified (male donor/male recipient, N=10 750;...

10.1161/circheartfailure.108.844183 article EN Circulation Heart Failure 2009-07-09

<h3>Importance</h3> Delirium occurs in up to 52% of patients after cardiac surgery and may result from changes cerebral perfusion. Using intraoperative autoregulation monitoring individualize optimize perfusion be a useful strategy reduce the incidence delirium surgery. <h3>Objective</h3> To determine whether targeting mean arterial pressure during cardiopulmonary bypass (CPB) using reduces compared with usual care. <h3>Design, Setting, Participants</h3> This randomized clinical trial nested...

10.1001/jamasurg.2019.1163 article EN JAMA Surgery 2019-05-22

An increasing number of patients older than 65 years are referred for and have access to organ transplantation, an adults donating organs. Although short-term outcomes similar in versus younger transplant recipients, donor or recipient age is associated with inferior long-term outcomes. However, often a proxy other factors that might predict poor more strongly better identify at risk adverse events. Approaches transplantation vary across programs, but despite recent gains the increased use...

10.1111/j.1600-6143.2012.04245.x article EN cc-by-nc-nd American Journal of Transplantation 2012-09-07
Coming Soon ...